Epidermal growth factor receptor tyrosine kinase inhibitor treatment in patients with EGFR wild-type non-small-cell lung cancer: the never-ending story
- PMID: 23940223
- DOI: 10.1200/JCO.2013.50.2617
Epidermal growth factor receptor tyrosine kinase inhibitor treatment in patients with EGFR wild-type non-small-cell lung cancer: the never-ending story
Comment in
-
Gene expression profiling of localized prostate cancer: getting answers to the questions that really matter.J Clin Oncol. 2013 Sep 10;31(26):3295-6. doi: 10.1200/JCO.2013.51.0420. Epub 2013 Aug 12. J Clin Oncol. 2013. PMID: 23940217 No abstract available.
-
Reply to F. Gelsomino et al.J Clin Oncol. 2013 Sep 10;31(26):3293-4. doi: 10.1200/JCO.2013.50.8705. Epub 2013 Aug 12. J Clin Oncol. 2013. PMID: 23943831 No abstract available.
-
Reply to A. Azad et al.J Clin Oncol. 2013 Sep 10;31(26):3296-7. doi: 10.1200/JCO.2013.51.4919. Epub 2013 Aug 12. J Clin Oncol. 2013. PMID: 23943835 No abstract available.
Comment on
-
Role of epidermal growth factor receptor inhibitors in epidermal growth factor receptor wild-type non-small-cell lung cancer.J Clin Oncol. 2013 Mar 10;31(8):1061-9. doi: 10.1200/JCO.2012.43.4522. Epub 2013 Feb 11. J Clin Oncol. 2013. PMID: 23401452 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous